Singapore pharma on recovery path after worst output in decades
SINGAPORE (Reuters) - Singapore's pharmaceuticals business, among the pillars of the city-state's manufacturing sector, is set to return to strength this year as big global drugmakers ramp up output and advance automation at their production sites across the country.
from Reuters: Health News https://reut.rs/2pEiVnD
http://bit.ly/2zwRqiM